First Treatment in China for Morquio A Syndrome Earns Approval
Free-Photos / Pixabay

First Treatment in China for Morquio A Syndrome Earns Approval

According to a story from Market Screener, the biotechnology company BioMarin Pharmaceutical Inc. recently announced that the Chinese government has approved the company's drug elosulfase alfa (marketed at Vimizim) as…

Continue Reading First Treatment in China for Morquio A Syndrome Earns Approval
Potential Treatment for BRCA Mutated Pancreatic Cancer Performs Well in Trial
mohamed_hassan / Pixabay

Potential Treatment for BRCA Mutated Pancreatic Cancer Performs Well in Trial

According to a story from BioPortfolio, AstraZeneca and Merck have recently announced the results from a phase 3 clinical trial testing olaparib (marketed as LYNPARZA®) as a treatment for BRCA…

Continue Reading Potential Treatment for BRCA Mutated Pancreatic Cancer Performs Well in Trial

Study Links IL-1 Cytokines to Increased Scarring in Systemic Scleroderma Patients

According to a publication from Scleroderma News, a study recently published in Clinical & Transitional Immunology suggests that certain cytokines (small proteins that play an important role in communication between…

Continue Reading Study Links IL-1 Cytokines to Increased Scarring in Systemic Scleroderma Patients
Gene Therapy for Severe Beta Thalassemia Earns Conditional Marketing Approval in the EU
ColiN00B / Pixabay

Gene Therapy for Severe Beta Thalassemia Earns Conditional Marketing Approval in the EU

According to a story from BioPortfolio, the gene therapy company bluebird bio, Inc. recently announced that its gene therapy ZYNTEGLO™ has earned conditional marketing authorization in the European Union from…

Continue Reading Gene Therapy for Severe Beta Thalassemia Earns Conditional Marketing Approval in the EU
Orchard Therapeutics Acquires Global Licensing Agreement for Experimental Mucopolysaccharidosis Drug
source: pixabay.com

Orchard Therapeutics Acquires Global Licensing Agreement for Experimental Mucopolysaccharidosis Drug

According to a publication from Biospace, British clinical drug developer Orchard Therapeutics has secured global intellectual property rights to research, manufacture, and market a gene therapy program for the treatment…

Continue Reading Orchard Therapeutics Acquires Global Licensing Agreement for Experimental Mucopolysaccharidosis Drug
Bayer’s Aliqopa Receives Breakthrough Therapy Status for Marginal Zone Lymphoma
source: pixabay.com

Bayer’s Aliqopa Receives Breakthrough Therapy Status for Marginal Zone Lymphoma

According to a publication from Benzinga, the U.S. Food and Drug Administration has granted Breakthrough Therapy status to Bayer's relapsed follicular lymphoma drug Aliqopa (copanlisib) for the treatment of marginal…

Continue Reading Bayer’s Aliqopa Receives Breakthrough Therapy Status for Marginal Zone Lymphoma

Wheelchair Bound Spina Bifida Patient Finishes Top 12 in National CrossFit Competition After One Year of Training

Sydney Mccallister is a 32-year-old woman diagnosed with spina bifida. Essentially, the condition means that the neural tube has not closed all the way during the first month of embryonic…

Continue Reading Wheelchair Bound Spina Bifida Patient Finishes Top 12 in National CrossFit Competition After One Year of Training

The Challenge: He is A Father, A Caregiver and A Scientist Trying to Save his Son and Others With ME/CFS or Chronic Fatigue Syndrome

  Ron Davis and his gene-sequencing technologies were mentioned years ago in The Atlantic alongside Elon Musk (SpaceX) and Jeff Bezos of Amazon fame. Since then, Davis has amassed over…

Continue Reading The Challenge: He is A Father, A Caregiver and A Scientist Trying to Save his Son and Others With ME/CFS or Chronic Fatigue Syndrome
Company Seeks Marketing Approval for Possible Duchenne Muscular Dystrophy Drug in EU
Capri23auto / Pixabay

Company Seeks Marketing Approval for Possible Duchenne Muscular Dystrophy Drug in EU

According to a story from BioPortfolio, the specialty pharmaceutical company Santhera Pharmaceuticals recently announced that it has submitted its marketing application to the European Medicines Agency (EMA) for its drug…

Continue Reading Company Seeks Marketing Approval for Possible Duchenne Muscular Dystrophy Drug in EU
NIH Grants Funding for Scientist’s Heparin-Induced Thrombocytopenia Biomarker Research
source: pixabay.com

NIH Grants Funding for Scientist’s Heparin-Induced Thrombocytopenia Biomarker Research

According to a publication on EurekAlert, the National Institutes of Health recently awarded Dr. Jason Karnes, PharmD, PhD (and assistant professor in the University of Arizona College of Pharmacy) with…

Continue Reading NIH Grants Funding for Scientist’s Heparin-Induced Thrombocytopenia Biomarker Research
Could Blood Donations Improve Diagnostic Rates for Familial Hypercholesterolemia?
sabinurce / Pixabay

Could Blood Donations Improve Diagnostic Rates for Familial Hypercholesterolemia?

According to a story from brightsurf.com, familial hypercholesterolemia, a genetic condition that causes elevated levels of LDL cholesterol to appear at a young age, often goes undiagnosed. In fact, some…

Continue Reading Could Blood Donations Improve Diagnostic Rates for Familial Hypercholesterolemia?
Senator Cruz Encourages FDA to Expand Number of Conditions Covered by Parallel Track Policy
courtesy of US Gov't

Senator Cruz Encourages FDA to Expand Number of Conditions Covered by Parallel Track Policy

In a letter to Dr. Norman Sharpless, the acting commissioner of the Food and Drug Administration since April 5, Senator Ted Cruz encouraged the federal agency to expand the number…

Continue Reading Senator Cruz Encourages FDA to Expand Number of Conditions Covered by Parallel Track Policy

Patient Registry Reveals Critical Information About Idiopathic Pulmonary Fibrosis

According to a story from blogs.biomedcentral.com, the findings from the IPF-PRO Registry, which is a US-based registry for idiopathic pulmonary fibrosis patients, were recently published. Patient registries are a critical…

Continue Reading Patient Registry Reveals Critical Information About Idiopathic Pulmonary Fibrosis
Age at Myeloproliferative Neoplasm Diagnosis Has Little Impact on Mortality Risk Says New Study
qimono / Pixabay

Age at Myeloproliferative Neoplasm Diagnosis Has Little Impact on Mortality Risk Says New Study

According to a publication from Oncology Nurse Advisor, a study of 109 patients with myeloproliferative neoplasms (certain types of blood cancers) found that mortality rates for younger patients were similar…

Continue Reading Age at Myeloproliferative Neoplasm Diagnosis Has Little Impact on Mortality Risk Says New Study